Tag: Therapeutics

Viridian Therapeutics to Webcast Veligrotug Part 3 THRIVE-2 Topline Outcomes on December 16, 2024 By Investing.com

- THRIVE-2 world section 3 medical trial evaluated efficacy and security of…

By Tycoon Herald 5 Min Read

Janux Therapeutics CEO sells $1 million in inventory By Investing.com

David Alan Campbell, President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), lately…

By Tycoon Herald 3 Min Read

Rakovina Therapeutics Proclaims Personal Placement Providing By Investing.com

VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…

By Tycoon Herald 7 Min Read

Roche to amass US agency Poseida Therapeutics in $1.5 billion deal By Reuters

ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in…

By Tycoon Herald 2 Min Read

Omega Therapeutics inventory hits 52-week low at $0.89 By Investing.com

In a difficult yr for Omega Therapeutics, the biotechnology agency's inventory has…

By Tycoon Herald 4 Min Read

EcoR1 Capital sells $8.4 million in Tango Therapeutics inventory By Investing.com

SAN FRANCISCO—EcoR1 Capital, LLC, a big shareholder in Tango Therapeutics, Inc. (NASDAQ:TNGX),…

By Tycoon Herald 4 Min Read

United Therapeutics shares rated Impartial by Ladenburg, goal lifted on Tyvaso gross sales energy By Investing.com

On Thursday, Ladenburg Thalmann up to date its monetary outlook on United…

By Tycoon Herald 2 Min Read